CDH2 and myocardial infarction: Lee et al. (2012) showed different angiogenic potency that correlated with therapeutic potential of four hUCB-MSCs lines in a mouse model of MI, that could be linked to individual differences in the expression of N-cadherin, resulting in overactivated ERK that lead to increased VEGF signaling.